Relationships between insulin resistance and lipoproteins in nondiabetic african americans, hispanics, and non-hispanic whites: The insulin resistance atherosclerosis study

Metabolism: Clinical and Experimental

Volumn 47, Issue 10, 1998, Pages 1174-1179

  Howard, Barbara V ^a   Mayer Davis, Elizabeth J ^b   Goff, David ^b   Zaccaro, Daniel J ^b   Laws, Ami ^b   Bobbins, David C ^b   Saad, Mohammad F ^b   Selby, Joseph ^b   Hamman, Richard F ^b   Krauss, Ronald M ^b   Haffner, Steven M ^b  

^a Medlantic Research Institute   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 13144294008     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90319-5     Document Type: Article

References (60)

1. Reaven GM, Lerner RL, Stern MP, et al: Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46:1756-1767, 1967
2. Olefsky JM, Reaven GM: Decreased insulin binding to lymphocytes from diabetic subjects. J Clin Invest 54:1323-1328, 1974
3. Abbott WGH, Lillioja S, Young AA, et al: Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 36:897-904, 1987
4. Garg AJ, Helderman H, Koffler M, et al: Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37:982-987, 1988
5. Laakso M, Sarlund H, Mykkanen L: Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10:223-231, 1990
6. Godsland IF, Crook D, Walton C, et al: Influence of insulin resistance, secretion, and clearance on serum cholesterol, triglycerides, lipoprotein cholesterol, and blood pressure in healthy men. Arterioscler Thromb 12:1030-1035, 1992
7. Reaven GM, Chen YDI, Jeppesen J, et al: Insulin resistance and hyperinsulinemia in individuals with small dense low density lipoprotein particles. J Clin Invest 92:141-146, 1993
8. Austin MA, Selby JV: LDL subclass phenotypes and the risk factors of the insulin resistance syndrome. Int J Obes Relat Metab Disord 19:S22-S26, 1995 (suppl 1)
9. Wagenkneckt LE, Mayer EJ, Rewers M, et al: The Insulin Resistance Atherosclerosis Study (IRAS). Objectives, design and recruitment results. Ann Epidemiol 5:464-471, 1995
10. Hamman RF, Marshall JA, Baxter J, et al: Methods and prevalence of non-insulin dependent diabetes mellitus in a biethnic Colorado population: The San Luis Valley Diabetes Study. Am J Epidemiol 129:295-311, 1989
11. Stern MP, Rosenthal M, Haffner SM, et al: Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: The San Antonio Heart Study. Am J Epidemiol 120:834-851, 1984
12. Haffner SM, D'Agostino R Jr, Saad MF, et al: Increased insulin resistance and insulin secretion in nondiabetic African Americans and Hispanics compared with non-Hispanic whites: The Insulin Resistance Atherosclerosis Study. Diabetes 45:742-748, 1996
13. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-86, 1985
14. World Health Organization: Diabetes mellitus: Report of a WHO study group. World Health Org Tech Rep Ser 727; 1985
15. Bergman RN, Ider YZ, Bowden CR: Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-E677, 1979
16. Bergman RN, Prager R, Volund A: Equivalence of the insulin sensitivity index in man derived by the minimal model and the euglycemic glucose clamp. J Clin Invest 79:790-800, 1987
17. Welch S, Gebhart SSP, Bergman RN, et al: Minimal model analysis of intravenous glucose tolerance test derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71:1508-1518, 1990
18. Howard G, O'Leary DH, Zaccaro D, et al: Insulin sensitivity and atherosclerosis. Circulation 93:1809-1817, 1996
19. Saad MF, Steil GM, Kades WW, et al: Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes 46:1167-1171, 1997
20. Steil GM, Volund A, Kahn SE, et al: Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 42:250-256, 1993
21. Herbert V, Lau K, Gottlieb C, et al: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965
22. Pacini G, Bergman RN: MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122, 1986
23. Robbins DC, Welty TK, Wang WY, et al: Plasma lipids and lipoprotein concentrations among American Indians: Comparison with the US population. Curr Opin Lipidol 7:188-195, 1996
24. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
25. Neter J, Wasserman W, Kutner MH: Applied Linear Statistical Models (ed 3). Homewood, IL, Richard D. Irwin, 1990
26. SAS Institute: SAS/STAT User's Guide, version 6, vol 2 (ed 4). Cary, NC, SAS Institute, 1989
27. Orchard TJ, Becker DJ, Bates M, et al: Plasma insulin and lipoprotein concentrations: An atherogenic association? Am J Epidemiol 118:326-337, 1983
28. Howard BV, Knowler WC, Vasquez B, et al: Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian population. Arteriosclerosis 4:462-471, 1984
29. Cambien F, Warnet JM, Eschwege E, et al: Body mass, blood pressure, glucose, and lipids: Does plasma insulin explain their relationships? Arteriosclerosis 7:187-202, 1987
30. Donahue RP, Orchard TJ, Becker DJ, et al: Sex differences in the coronary heart disease risk profile: A possible role for insulin. Am J Epidemiol 125:650-657, 1987
31. Haffner SM, Fing D, Hazuda HP, et al: Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 37:338-345, 1988
32. Burchfiel CM, Hammon RF, Marshall JA, et al: Cardiovascular risk factors and impaired glucose tolerance: The San Luis Valley Diabetes Study. Am J Epidemiol 131:57-70, 1990
33. McKeigue PM, Miller GJ, Marmot MG: Coronary heart disease in South Asians overseas: A review. J Clin Epidemiol 42:597-609, 1989
34. Modan M, Halkin H, Lusky A, et al: Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. Arteriosclerosis 8:227-236, 1988
35. Zavaroni I, Dall' Anglio E, Alpi O, et al: Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55:259-266, 1985
36. Manolio TA, Savage PJ, Burke GL, et al: Association of fasting insulin with blood pressure and lipids in young adults. Arteriosclerosis 10:430-436, 1990
37. Mykkanen L, Kuusisto J, Haffner SM, et al: Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscler Thromb 14:518-526, 1994
38. Reaven EP, Reaven GM: Mechanisms for development of diabetic hypertriglyceridemia in streptozotocin treated rats: Effect of diet and duration of insulin deficiency. J Clin Invest 54:167-178, 1974
39. Kissebah A: Insulin actions in vivo: Insulin and lipoprotein metabolism, in Alberti KGMM, Zimmet P, DeFronzo RA (eds): International Textbook of Diabetes Mellitus. Biochemistry and Pathophysiology. West Sussex, UK, 1992, pp 439-458
40. Sparks CE, Sparks JD, Bolognino M, et al: Insulin effects on apolipoprotein synthesis and secretion by primary cultures of rat hepatocytes. Metabolism 35:1128-1136, 1986
41. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628, 1987
42. Lewis GF, Uffelman KD, Szeto LW, et al: Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 42:833-842, 1993
43. Peiris AN, Aiman EJ, Drucker WD, et al: The relative contributions of hepatic and peripheral tissue to insulin resistance in hyperandrogenic women. J Clin Endocrinol Metab 68:715-720, 1989
44. Fujioka S, Matsuzawa Y, Tokunage K, et al: Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36:54-59, 1987
45. Anderson AJ, Sobocinski KA, Freedman DS, et al: Body fat distribution, plasma lipids, and lipoproteins. Arteriosclerosis 8:88-94, 1988
46. Laws A, Hoen HM, Selby JV, et al: Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status: Relation to plasma triglyceride and apolipoprotein B concentrations. Arterioscler Thromb Vasc Biol 17:64-71, 1997
47. Pollare T, Vessby B, Lithell H: Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb 11:1192-1203, 1991
48. Howard BV, Howard WJ: Dyslipidemia in non-insulin-dependent diabetes mellitus. Endocr Rev 15:263-274, 1993
49. Knudsen P, Eriksson J, Lahdenpera S, et al: Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group. Diabetologia 38:344-350, 1995
50. Van Tol A, Ligtenberg JJ, Riemens SC, et al: Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scand J Clin Lab Invest 57:147-157, 1997
51. Dullaart RP, Sluiter WJ, Dikkeschei LD, et al: Effect of adiposity on plasma lipid transfer protein activities: A possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 24:188-194, 1994
52. Shames DM, Yamada N, Havel RJ: Metabolism of apoB-100 in lipoproteins separated by density gradient ultracentrifugation in normal and Watanabe heritable hyperlipidemic rabbits. J Lipid Res 31:753-762, 1990
53. Gaw A, Packard CJ, Murray EF, et al: Effects of simvastatin on apoB metabolism and LDL subfraction distribution. Arterioscler Thromb 12:170-189, 1993
54. Deckelbaum RJ, Granot E, Oschry Y, et al: Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 4:225-231, 1984
55. Després J-P, Allard C, Tremblay A, et al: Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 34:967-973, 1985
56. Porte D: Banting Lecture 1990: β Cells in type II diabetes mellitus. Diabetes 40:166-180, 1991
57. Haffner SM, Bowsher RR, Mykkanen L, et al: Proinsulin and specific insulin concentration in high and low risk populations for non-insulin dependent diabetes mellitus. Diabetes 43:1490-1493, 1994
58. Ward WK, LaCava EC, Paquette TL, et al: Disproportionate elevation of immunoreactive proinsulin in type II (non-insulin dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698-702, 1987
59. Yoshioka N, Kuzuya T, Matsuda A, et al: Serum proinsulin levels at fasting and after oral glucose load in patients with type II (non-insulin dependent) diabetes mellitus. Diabetologia 31:355-360, 1988
60. Davies MJ, Rayman G, Gray IP, et al: Insulin deficiency and increased plasma concentrations of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 10:313-320, 1993